Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, and pharmacokinetics of the experimental drug SSS11 in patients with gout and hyperuricemia; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• SSS11 (SSS11)

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Gout, Hyperuricemia | Phase 1 | Status: RECRUITING